TCM
Tang Capital Management Portfolio holdings
AUM
$1.98B
1-Year Return
21.62%
This Quarter Return
+11.67%
1 Year Return
+21.62%
3 Year Return
+290.69%
5 Year Return
+284.46%
10 Year Return
+928.34%
AUM
$688M
AUM Growth
-$127M
(-16%)
Cap. Flow
-$136M
Cap. Flow
% of AUM
-19.74%
Top 10 Holdings %
Top 10 Hldgs %
47.84%
Holding
112
New
17
Increased
24
Reduced
32
Closed
23
Top Buys
| 1 |
Axsome Therapeutics
AXSM
|
$19.3M |
| 2 |
Vaxcyte
PCVX
|
$14.4M |
| 3 |
Moderna
MRNA
|
$14.4M |
| 4 |
Mirum Pharmaceuticals
MIRM
|
$13.1M |
| 5 |
BioAtla
BCAB
|
$9.55M |
Top Sells
| 1 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
$42.3M |
| 2 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
$21.2M |
| 3 |
Rocket Pharmaceuticals
RCKT
|
$20.2M |
| 4 |
Bio-Rad Laboratories Class A
BIO
|
$18.1M |
| 5 |
ALBO
Albireo Pharma, Inc. Common Stock
ALBO
|
$14.9M |
Sector Composition
| 1 | Healthcare | 98.38% |
| 2 | Consumer Discretionary | 0.64% |
| 3 | Communication Services | 0% |
| 4 | Consumer Staples | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ELEV
76
DELISTED
Elevation Oncology
ELEV
| $456K | 0.07% |
+479,854
| New | +$456K |
|
77
Talphera
TLPH
$10.6M
| $441K | 0.06% |
195,000
+175,577
| +904% | +$397K |
|
78
CRISPR Therapeutics
CRSP
$4.8B
| $407K | 0.06% |
10,000
-40,000
| -80% | -$1.63M |
|
79
Nektar Therapeutics
NKTR
$684M
| $371K | 0.05% |
10,946
-17,723
| -62% | -$601K |
|
|
SURF
80
DELISTED
Surface Oncology, Inc. Common Stock
SURF
| $352K | 0.05% |
+429,647
| New | +$352K |
|
81
Relmada Therapeutics
RLMD
$45.5M
| $349K | 0.05% |
100,000
-300,000
| -75% | -$1.05M |
|
|
ATYR
82
aTyr Pharma
ATYR
$536M
| $270K | 0.04% |
123,430
-990,023
| -89% | -$2.17M |
|
83
Gossamer Bio
GOSS
$571M
| $217K | 0.03% |
100,000
-150,000
| -60% | -$326K |
|
|
MOLN
84
Molecular Partners
MOLN
$133M
| $144K | 0.02% |
22,000
+6,319
| +40% | +$41.4K |
|
|
VINC
85
DELISTED
Vincerx Pharma, Inc. Common Stock
VINC
| $104K | 0.02% |
5,088
-46,444
| -90% | -$947K |
|
86
Reviva Pharmaceuticals
RVPH
$30.4M
| $103K | 0.01% |
+24,125
| New | +$103K |
|
|
LIAN
87
DELISTED
LianBio American Depositary Shares
LIAN
| $97.7K | 0.01% |
+59,600
| New | +$97.7K |
|
|
OKUR
88
OnKure Therapeutics, Inc. Class A Common Stock
OKUR
$36.4M
| $71.3K | 0.01% |
+3,059
| New | +$71.3K |
|
|
PRDS
89
DELISTED
Pardes Biosciences, Inc. Common Stock
PRDS
| $57K | 0.01% |
33,748
-466,252
| -93% | -$788K |
|
90
ADMA Biologics
ADMA
$4.04B
| – | – |
-992,840
| Closed | -$2.41M |
|
91
Alector
ALEC
$285M
| – | – |
-100,000
| Closed | -$946K |
|
92
ANI Pharmaceuticals
ANIP
$2.08B
| – | – |
-100,000
| Closed | -$3.21M |
|
93
BridgeBio Pharma
BBIO
$9.91B
| – | – |
-585,424
| Closed | -$5.82M |
|
94
Clene
CLNN
$59.4M
| – | – |
-55,000
| Closed | -$3.08M |
|
95
Day One Biopharmaceuticals
DAWN
$759M
| – | – |
-400,000
| Closed | -$8.01M |
|
96
Equillium
EQ
$104M
| – | – |
-600,000
| Closed | -$1.33M |
|
97
Esperion Therapeutics
ESPR
$510M
| – | – |
-500,000
| Closed | -$3.35M |
|
98
Fortress Biotech
FBIO
$84.5M
| – | – |
-279,632
| Closed | -$3.61M |
|
99
Inspirato
ISPO
$36.5M
| – | – |
-30,617
| Closed | -$1.45M |
|
|
100
Inspirato Incorporated Warrant
ISPOW
$81.9K
| – | – |
-365,000
| Closed | -$88K |
|